Intrathecal implants of bovine chromaffin cells alleviate mechanical allodynia in a rat model of neuropathic pain

Pain

Volumn 76, Issue 1-2, 1998, Pages 159-166

  Decosterd I ^a,b   Buchser, E ^b   Gilliard, N ^a   Saydoff, J ^c   Zurn, A D ^a   Aebischer, P ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Hospital of Morges   (Switzerland)

^c CytoTherapeutics Inc   (United States)

Author keywords

Catecholamine; Cell transplantation; Chromaffin cell; Encapsulation; Neuropathic pain; Opioid

Indexed keywords

ALLODYNIA; ANALGESIA; ANIMAL MODEL; ARTICLE; CATECHOLAMINE RELEASE; CATTLE; CELL TRANSPLANTATION; CHROMAFFIN CELL; CHRONIC PAIN; CONTROLLED STUDY; ENCAPSULATION; MALE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; CATECHOLAMINES; CATTLE; CELL TRANSPLANTATION; CHROMAFFIN CELLS; ENKEPHALIN, METHIONINE; MALE; NEUROPEPTIDES; PAIN; PAIN MEASUREMENT; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SPINAL CORD; TRANSPLANTATION, HETEROLOGOUS;

EID: 0344589392     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00044-X     Document Type: Article

References (37)

1. Aebischer P., Tresco P.A., Winn S.R., Greene L.A., Jaeger C.B. Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Exp. Neurol. 111:1991;269-275.
2. Aebischer P., Buchser E., Joseph J.M., Favre J., de Tribolet N., Lysaght M., Rudnick S., Goddard M. Transplantation in humans of encapsulated xenogeneic cells without immunosuppression. A preliminary report. Transplantation. 58:1994;1275-1277.
3. Aebischer P., Schluep M., Deglon N., Joseph J.M., Hirt L., Heyd B., Goddard M., Hammang J.P., Zurn A.D., Kato A.C., Regli F., Baetge E.E. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells In amyotrophic lateral sclerosis patients. Nat. Med. 2:1996;696-699.
4. Apfel S.C., Kessler J.A. Neurotrophic factors in the therapy of peripheral neuropathy. Bailliere's Clin. Neurol. 4:1995;593-606.
5. Bennett, G.J., Neuropathic pain. In: P.D. Wall and R. Melzack (Eds.), Textbook of Pain, Churchill Livingstone, Edinburgh, 1994, pp. 201-224.
6. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
7. Buchser E., Goddard M., Heyd B., Joseph J.M., Favre J., de Tribolet N., Lysaght M., Aebischer P. Immunoisolated xenogeneic chromaffin cell therapy for chronic pain - initial clinical experience. Anesthesiology. 85:1996;1005-1012.
8. Choi Y., Yoon Y.W., Na H.S., Kim S.H., Chung J.M. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain. 59:1994;369-376.
9. Coderre T.J., Katz J., Vaccarino A.L., Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 52:1993;259-285.
10. Czech K.A., Sagen J. Update on cellular transplantation into the CNS as a novel therapy for chronic pain. Prog. Neurobiol. 46:1995;507-529.
11. Ginzburg R., Seltzer Z. Subarachnoid spinal cord transplantation of adrenal medulla suppresses chronic neuropathic pain behavior in rats. Brain Res. 523:1990;147-150.
12. Gracely R.H., Lynch S.A., Bennett G.J. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain. 51:1992;175-194.
13. Hama A.T., Pappas G.D., Sagen J. Adrenal medullary implants reduce transsynaptic degeneration in the spinal cord of rats following chronic constriction nerve injury. Exp. Neurol. 137:1996;81-93.
14. Hama A.T., Sagen J. Reduced pain-related behavior by adrenal medullary transplants in rats with experimental painful peripheral neuropathy. Pain. 52:1993;223-231.
15. Hama A.T., Sagen J. Alleviation of neuropathic pain symptoms by xenogeneic chromaffin cell grafts in the spinal subarachnoid space. Brain Res. 651:1994;183-193.
16. Hökfelt T., Zhang X., Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci. 17:1994;22-30.
17. Kajander K.C., Madsen A.M., Iadarola M.J., Draisci G., Wakisaka S. Fos-like immunoreactivity increases in the lumbar spinal cord following a chronic constriction injury to the sciatic nerve of rat. Neurosci. Lett. 206:1996;9-12.
18. 2-adrenergic agonists in chronic neuropathic pain. Stereotact. Funct. Neurosurg. 62:1994;279-289.
19. Livett B.G., Dean D.M., Whelan L.G., Udenfriend S., Rossier J. Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells. Nature. 289:1981;317-319.
20. Merskey, H. and Bogduck, N. (Eds.), Classification of Chronic Pain, IASP Press, Seattle, WA, 1994, 222 pp.
21. Nahin R.L., Ren K., De Leon M., Ruda M. Primary sensory neurons exhibit altered gene expression in a rat model of neuropathic pain. Pain. 58:1994;95-108.
22. Ortega-Alvaro A., Gibert-Rahola J., Chover A.J., Tejedor-Real P., Casas J., Mico J.A. Effect of amitriptyline on the analgesia induced by adrenal medullary tissue transplanted in the rat spinal subarachnoid space as measured by an experimental model of acute pain. Exp. Neurol. 130:1994;9-14.
23. Ossipov M.H., Lopez Y., Bian D., Nichols M.L., Porreca F. Synergistic antinociceptive interactions of morphine and clonidine in rats with nerve-ligation injury. Anesthesiology. 86:1997;196-204.
24. Sagen J., Pappas G.D., Perlow M.J. Adrenal medullary tissue transplants in the rat spinal cord reduce pain sensitivity. Brain Res. 384:1986;189-194.
25. Sagen J., Kemmler J.E. Increased levels of Met-enkephalin-like immunoreactivity in the spinal cord CSF of rats with adrenal medullary transplants. Brain Res. 502:1989;1-10.
26. Sagen J., Wang H., Tresco P.A., Aebischer P. Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances. J. Neurosci. 13:1993;2415-2423.
27. Siegan J.B., Sagen J. Attenuation of NMDA-induced spinal hypersensitivity by adrenal medullary transplants. Brain Res. 680:1995;88-98.
28. Steiner J.P., Connolly M.A., Valentine H.L., Hamilton G.S., Dawson T.M., Hester L., Snyder S.H. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat. Med. 3:1997;421-428.
29. Tal M., Bennett G.J. Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve. Pain. 57:1994;375-382.
30. Unsicker K., Krieglstein K. Growth factors in chromaffin cells. Prog. Neurobiol. 48:1996;307-324.
31. Viveros O.H., Wilson S.P. The adrenal chromaffin cell as a model to study the co-secretion of enkephalins and catecholamines. J. Autonomic Nerv. Syst. 7:1983;41-58.
32. Wang H., Sagen J. Absence of appreciable tolerance and morphine cross-tolerance in rats with adrenal medullary transplants in the spinal cord. Neuropharmacology. 33:1994;681-692.
33. Winnie A.P., Pappas G.D., Das Gupta T.K., Wang H., Ortega J.D., Sagen J. Subarachnoid adrenal medullary transplants for terminal cancer pain. A report of preliminary studies. Anesthesiology. 79:1993;644-653.
34. Woolf C.J., Thompson S.W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-299.
35. Xu J.Y., Pollock C.H., Kajander K.C. Chronic gut suture reduces calcitonin-gene-related peptide and substance P levels in the spinal cord following chronic constriction injury In the rat. Pain. 64:1996;503-509.
36. Yaksh T.L., Reddy S.V. Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. Anesthesiology. 54:1981;451-467.
37. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.